Sientra, Inc.

Contact KTMC
Free Consultation
* denotes required fields
I agree to the KTMC disclaimer
I would like to receive new case alerts by email

Investigation of Potential Action on Behalf of Sientra, Inc. (Nasdaq: SIEN)

Kessler Topaz Meltzer & Check, LLP is investigating a potential action on behalf of current shareholders of Sientra, Inc. (“Sientra”).

About Sientra, Inc.

Sientra is a medical aesthetics company, which develops and sells medical aesthetics products to plastic surgeons in the United States. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders. It also provides body contouring and other implants, including gluteal, pectoral, calf, facial and nasal implants, and nasal stents; silicone elastomer oval carving blocks to treat congenital and other deformities caused by trauma or tumor removal; scar management products under the Medgel brand; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use.

Alleged Wrongful Conduct

Kessler Topaz Meltzer & Check, LLP is investigating potential breaches of fiduciary duties by members of Sientra’s Board of Directors, which may have caused harm to the company and its shareholders.

If you currently own shares of Sientra, Inc. (Nasdaq: SIEN) and would like to learn more about our investigation, please fill out our online form or contact us today at 888-299-7706 or